Connecticut HB5389: AN ACT CONCERNING A PROVIDER TOOLKIT FOR THE DIAGNOSIS AND TREATMENT OF MENOPAUSE, PERIMENOPAUSE AND POSTMENOPAUSE.

What the bill says

An act concerning a provider toolkit for the diagnosis and treatment of menopause, perimenopause and postmenopause. assembly convened.

From the introduced text:

AN ACT CONCERNING A PROVIDER TOOLKIT FOR THE DIAGNOSIS AND TREATMENT OF MENOPAUSE, PERIMENOPAUSE AND POSTMENOPAUSE. Assembly convened: Section 1. (NEW) (Effective October 1, 2026) (a) The Department of Public Health, in consultation with The University of Connecticut Health Center's Health Disparities Institute, shall develop a toolkit that provides practical, evidence-based and culturally appropriate guidance to health care providers in the state who are responsible for diagnosing or treating persons with symptoms of menopause, perimenopause or postmenopause, as determined by the commissioner, including, but not limited to, health care providers in the fields of obstetrics, gynecology, internal medicine, family medicine, emergency medicine, psychiatry, mental health, social work, dentistry, dental hygiene and community health, regarding best practices for screening, identification, clinical assessment, diagnosis and treatment of symptoms of menopause, perimenopause and postmenopause. Such guidance shall include, but need not be limited to, (1) a comprehensive description of the symptoms of menopause, perimenopause and postmenopause, (2) evidence-based LCO No. 2186 1 of Raised Bill No. 5389 guidelines regarding the identification and treatment of such symptoms, including, but not limited to, the use of hormones, such as hormone replacement therapy and testosterone therapy, (3) the availability of insurance coverage for such therapies, and (4) short education modules regarding such guidance that would qualify as continuing education for such health care providers. (b) Not …

Read the full official text

Sponsors

• Kate Farrar (D, 20) · primary sponsor
• Kai Belton (D, 100)
• Kathleen Kennedy (R, 119)
• Nicholas Gauthier (D, 38)
• Eleni Kavros DeGraw (D, 17)
• Sarah Keitt (D, 134)
• Julie Kushner (D, 24)
• Antonio Felipe (D, 130)
• Martha Marx (D, 20)
• Laurie Sweet (D, 91)
• Amy Morrin Bello (D, 28)
• Trenee McGee (D, 116)

Latest actions

1. April 15, 2026: Tabled for the Calendar, House
2. April 15, 2026: No New File by Committee on Appropriations
3. April 14, 2026: Reported Out of Legislative Commissioners' Office
4. April 14, 2026: Filed with Legislative Commissioners' Office
5. April 13, 2026: Joint Favorable
6. April 7, 2026: Referred by House to Committee on Appropriations
7. March 23, 2026: File Number 114
8. March 23, 2026: House Calendar Number 108
9. March 23, 2026: Favorable Report, Tabled for the Calendar, House
10. March 23, 2026: Reported Out of Legislative Commissioners' Office

Votes

• APP Vote Tally Sheet (Joint Favorable) (April 14, 2026): 41 yea, 6 nay, passed
• PH Vote Tally Sheet (Joint Favorable Substitute) (March 9, 2026): 25 yea, 6 nay, passed

Common questions

What is HB5389?

HB5389 is a bill in the Connecticut Legislature (2026 General Assembly): AN ACT CONCERNING A PROVIDER TOOLKIT FOR THE DIAGNOSIS AND TREATMENT OF MENOPAUSE, PERIMENOPAUSE AND POSTMENOPAUSE.

What does HB5389 do?

In its own words: An act concerning a provider toolkit for the diagnosis and treatment of menopause, perimenopause and postmenopause. assembly convened.

What is the status of HB5389?

In committee as of April 15, 2026. Latest action: Tabled for the Calendar, House (April 15, 2026).

Who sponsored HB5389?

Kate Farrar (D, 20), with 11 co-sponsors.

Where is the official record for HB5389?

On the Connecticut Legislature website: https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=HB05389&which_year=2026